This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharmaceutical Compliance Congress (PCC) 2026
April 27-29, 2026
The Ritz-Carlton, Tysons Corner | McLean, VA

Peter Agnoletto
Ethics and Business Integrity Global Head for aT1D&CVM Franchise and US General Medicines Strategic Advisor at Sanofi
Speaker

Profile

Peter J. Agnoletto is Ethics and Business Integrity Global Head for the aT1D&CVM Franchise, and US General Medicines Strategic Advisor. Prior to Sanofi Peter was the Chief Compliance Officer and Chief Audit Executive at Par Pharmaceuticals Companies, Inc.

Peter is a Compliance and Financial executive with a demonstrated record of achievement in creating and implementing Governance Risk and Compliance frameworks and structures which protect companies’ interests while enabling them to achieve their growth objectives. Peter has over 20 years’ experience with multi-billion dollar international public companies and professional service organizations.

Agenda Sessions

  • Guardrails for Evolving Field Facing Roles

    3:50pm